 |
市场调查报告书
商品编码
1567167
胞外体诊断和治疗市场：按类型、按产品和服务、按来源、按应用、按最终用户、按地区Exosomes Diagnostic and Therapeutic Market, By Type, By Product & Service, By Source, By Application, By End User, By Geography |
||||||
全球胞外体诊断和治疗市场预计到2024年将达到7,820万美元，预计到2031年将达到2.561亿美元，2024年至2031年的复合年增长率为18.5%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 7820 万美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024年至2031年 |
| 预测 2024-2031 年复合年增长率： | 18.50% | 2031年价值预测 | 2.561 亿美元 |
近年来，全球胞外体诊断和治疗市场经历了显着成长。胞外体是奈米大小的细胞外囊泡，可作为蛋白质、脂质和核酸等生物分子的载体。它在细胞间通讯和免疫反应中发挥重要作用。胞外体在癌症、神经系统疾病和心血管疾病等各种疾病的诊断和治疗中的日益增长的应用正在推动该市场的成长。研发和医疗保健行业的参与者越来越多地利用胞外体的潜力来开发微创液态切片、药物输送解决方案和再生疗法。分离和表征技术的进步正在进一步扩大胞外体的研究和临床应用范围。
市场动态：
推动胞外体诊断和治疗市场的关键因素包括对非侵入性诊断的需求不断增长、目标疾病盛行率的增加、基于胞外体的疗法相对于传统药物的优越性以及我可以列出的技术进步。然而，与分离技术和表征工具相关的高成本和缺乏标准化正在限制市场成长。从积极的一面来看，准入的改善和持续的完善正在创造新的机会。抗衰老药物、不孕症治疗和感染疾病控制的新应用也充满希望。
本研究的主要特点
该报告对全球胞外体诊断和治疗市场进行了详细分析，并列出了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
它揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、业绩和策略等参数对全球胞外体诊断和治疗市场的主要企业进行了分析。
本研究涵盖的主要企业包括 Evox Therapeutics Ltd、Exosome Diagnostics、Aethlon Medical、NanoSomix Inc、Thermo Fisher Scientific、Malvern Panalytical 和 System Biosciences LLC。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球胞外体诊断和治疗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
相关人员可以透过用于分析全球胞外体诊断和治疗市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
第 4 章 全球胞外体诊断与治疗市场，按类型，2024-2031 年（百万美元）
- 胞外体诊断
- 胞外体疗法
第五章 全球胞外体诊断与治疗市场，依产品与服务划分，2024-2031 年（百万美元）
- 设备和服务
- 试剂套件和试剂
第六章 全球胞外体诊断与治疗市场，依来源划分，2024-2031 年（百万美元）
- 干细胞
- 血液和血浆
- 尿
- 其他资讯来源
第七章 全球胞外体诊断与治疗市场，依应用分类，2024-2031 年（百万美元）
- 癌症
- 皮肤病
- 肌肉骨骼疾病
- 心血管疾病
- 其他的
第 8 章 全球胞外体诊断与治疗市场，依最终使用者划分，2024-2031 年（百万美元）
- 医院和诊断中心
- 诊所和医生的治疗环境
- 学术研究所
- 合约调查机构
- 其他的
第9章全球胞外体诊断与治疗市场，按地区，2019-2031，价值（百万美元）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第10章竞争格局
- Thermo Fisher Scientific
- NanoSomix
- NX Pharmagen
- Malvern Instruments
- Capricor Therapeutic
- Exosome Diagnostics
- Exiqon A/S
- System Biosciences
- Exosome Sciences
- Aegle Therapeutic
- AMS Biotechnology
- Miltenyi Biotec
- Codiak BioSciences Inc.
- Lonza Group（HansaBioMed Life Sciences Ltd.）
- AcouSort AB
- Aethlon Medical, Inc.
- AGC Biologics
- Anjarium Biosciences AG
- Aruna Bio
- Brexogen
- Capricor Therapeutics
- Cells for Cells
- Ciloa
- ConvEyXO
第十一章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十二章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
The Global Exosomes Diagnostic and Therapeutic Market is estimated to be valued at USD 78.2 Mn in 2024 and is expected to reach USD 256.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 18.5% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 78.2 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 18.50% | 2031 Value Projection: | US$ 256.1 Mn |
The global exosomes diagnostic and therapeutic market has been witnessing significant growth in the recent years. Exosomes are nano-sized extracellular vesicles that act as carriers of biomolecules like proteins, lipids, and nucleic acids. They play an important role in cell-to-cell communication and immune response. The growing application of exosomes in diagnosis and treatment of various diseases like cancer, neurological disorders, and cardiovascular conditions is driving the growth of this market. Researchers and healthcare industry players are increasingly leveraging the potential of exosomes for developing minimally invasive liquid biopsies, drug delivery solutions, and regenerative therapies. Advancements in isolation and characterization techniques are further expanding the scope of research as well as clinical use of exosomes.
Market Dynamics:
The key drivers propelling the exosomes diagnostic and therapeutic market include growing demand for non-invasive diagnostic methods, increasing prevalence of target diseases, advantages of exosome-based therapies over conventional drugs, and technological advancements. However, high costs associated with isolation techniques and characterization tools, as well as lack of standardization are limiting the market growth. On the positive side, improved access and ongoing refinements are creating new opportunities. Emerging applications in anti-aging therapeutics, fertility management, and infection control also hold promise.
Key features of the study:
This report provides in-depth analysis of the global exosomes diagnostic and therapeutic market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global exosomes diagnostic and therapeutic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Evox Therapeutics Ltd, Exosome Diagnostics, Aethlon Medical, NanoSomix Inc, Thermo Fisher Scientific, Malvern Panalytical, System Biosciences LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global exosomes diagnostic and therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes diagnostic and therapeutic market.
Detailed Segmentation:
- By Type Insights (Revenue, USD Mn, 2019 - 2031)
- Exosome Diagnostics
- Exosome Therapeutics
- By Product & Service Insights (Revenue, USD Mn, 2019 - 2031)
- Instruments & Services
- Kits & Reagents
- By Source Insights (Revenue, USD Mn, 2019 - 2031)
- Stem Cells
- Blood & Blood Plasma
- Urine
- Other Sources
- By Application Insights (Revenue, USD Mn, 2019 - 2031)
- Cancer
- Dermatological Diseases
- Musculoskeletal Disorders
- Cardiovascular Diseases
- Others
- By End User Insights (Revenue, USD Mn, 2019 - 2031)
- Hospitals & Diagnostic Centers
- Clinics and Physician Settings
- Academic and Research Institutions
- Contract Research Organizations
- Others
- By Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- NanoSomix
- NX Pharmagen
- Malvern Instruments
- Capricor Therapeutic
- Exosome Diagnostics
- Exiqon A/S
- System Biosciences
- Exosome Sciences
- Aegle Therapeutic
- AMS Biotechnology
- Miltenyi Biotec
- Codiak BioSciences Inc.
- Lonza Group (HansaBioMed Life Sciences Ltd.)
- AcouSort AB
- Aethlon Medical, Inc.
- AGC Biologics
- Anjarium Biosciences AG
- Aruna Bio
- Brexogen
- Capricor Therapeutics
- Cells for Cells
- Ciloa
- ConvEyXO
Table of Contents
1. RESEARCH OBJECTIVES AND ASSUMPTIONS
- Research Objectives
- Assumptions
- Abbreviations
2. MARKET PURVIEW
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Exosomes Diagnostic and Therapeutic Market, By Type
- Global Exosomes Diagnostic and Therapeutic Market, By Product & Service
- Global Exosomes Diagnostic and Therapeutic Market, By Source
- Global Exosomes Diagnostic and Therapeutic Market, By Application
- Global Exosomes Diagnostic and Therapeutic Market, By End User
- Global Exosomes Diagnostic and Therapeutic Market, By Region
3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Exosomes Diagnostic and Therapeutic Market, By Type, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Exosome Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Exosome Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Exosomes Diagnostic and Therapeutic Market, By Product & Service, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Instruments & Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Kits & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Exosomes Diagnostic and Therapeutic Market, By Source, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Blood & Blood Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Other Sources
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Exosomes Diagnostic and Therapeutic Market, By Application, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Dermatological Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Exosomes Diagnostic and Therapeutic Market, By End User, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospitals & Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Clinics and Physician Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
9. Global Exosomes Diagnostic and Therapeutic Market, By Region, 2019 - 2031, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. COMPETITIVE LANDSCAPE
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NanoSomix
- NX Pharmagen
- Malvern Instruments
- Capricor Therapeutic
- Exosome Diagnostics
- Exiqon A/S
- System Biosciences
- Exosome Sciences
- Aegle Therapeutic
- AMS Biotechnology
- Miltenyi Biotec
- Codiak BioSciences Inc.
- Lonza Group (HansaBioMed Life Sciences Ltd.)
- AcouSort AB
- Aethlon Medical, Inc.
- AGC Biologics
- Anjarium Biosciences AG
- Aruna Bio
- Brexogen
- Capricor Therapeutics
- Cells for Cells
- Ciloa
- ConvEyXO
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
外泌体的全球市场 - 市场规模，预测，实验，趋势 (2024年)
胞外体市场规模、份额、趋势分析报告：按产品/服务、按工作流程、按应用、按最终用途、按地区、细分市场预测，2024-2030
全球外泌体市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测
全球外泌体技术市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测
外泌体分离市场 - 2024-2034 年全球产业分析、规模、份额、成长、趋势与预测
全球外泌体研究市场评估：依产品和服务、依适应症类型、依应用类型、依最终用户、依地区、机会、预测（2017-2031）
胞外体研究市场：按产品/服务、适应症、应用和最终用户 - 2024-2030 年全球预测
外泌体治疗市场 - 全球产业规模、份额、趋势、机会和预测，按外泌体类型、来源、治疗、应用、最终用户、地区和竞争细分，2019-2029F
胞外体研究的全球市场（~2028）：产品和服务（套件、试剂（抗体、分离和精製）、设备）、适应症（癌症、感染疾病）、用途（生物标记、疫苗）、製造服务（干细胞））其他
外泌体技术服务的全球市场的考察，预测(～2029年)